CA9 and breast carcinoma: Additionally, a study performed by our group with locally advanced breast tumor patients submitted to neoadjuvant chemotherapy showed that CAIX-positive expression was associated with higher disease-free survival and disease-specific survival, and a pathological complete response after treatment (25), suggesting that neoadjuvant therapy affects the metabolic phenotype of aggressive glycolytic tumors, favoring the clinical outcomes of breast cancer patients.